Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Medpace Holdings, Inc.

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Net New Business Awards

Net New Business Awards % Chg.

Total Backlog

Total Backlog % Chg.

Key Performance Indicators

Oncology Revenue

Oncology Revenue % Chg.

Oncology Revenue Common Size

Metabolic Revenue

Metabolic Revenue % Chg.

Metabolic Revenue Common Size

Other Sources of Revenue

Other Sources of Revenue % Chg.

Other Sources of Revenue Common Size

Cardiology Revenue

Cardiology Revenue % Chg.

Cardiology Revenue Common Size

Central Nervous System Revenue

Central Nervous System Revenue % Chg.

Central Nervous System Revenue Common Size

AVAI Revenue

AVAI Revenue % Chg.

AVAI Revenue Common Size

Total Revenue

Total Revenue Common Size

Total Revenue % Chg.

Revenue	LTM	Dec '24	Dec '23
Oncology Revenue	719.8	651.2	587.1
Metabolic Revenue	618	457.5	376.8
Other Sources of Revenue	423.5	431.4	404.8
Cardiology Revenue	234.6	230.5	193.7
Central Nervous System Revenue	230.9	182	160.1
AVAI Revenue	131.5	156.5	163.3
Total Revenue	2,358.4	2,109.1	1,885.8

Key Performance Indicators	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20
Net New Business Awards	2,439.8	2,230	2,356.7
Total Backlog	3,000.6	2,902.2	2,813